Literature DB >> 20170900

Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy.

Marina L Kennerson1, Garth A Nicholson, Stephen G Kaler, Bartosz Kowalski, Julian F B Mercer, Jingrong Tang, Roxana M Llanos, Shannon Chu, Reinaldo I Takata, Carlos E Speck-Martins, Jonathan Baets, Leonardo Almeida-Souza, Dirk Fischer, Vincent Timmerman, Philip E Taylor, Steven S Scherer, Toby A Ferguson, Thomas D Bird, Peter De Jonghe, Shawna M E Feely, Michael E Shy, James Y Garbern.   

Abstract

Distal hereditary motor neuropathies comprise a clinically and genetically heterogeneous group of disorders. We recently mapped an X-linked form of this condition to chromosome Xq13.1-q21 in two large unrelated families. The region of genetic linkage included ATP7A, which encodes a copper-transporting P-type ATPase mutated in patients with Menkes disease, a severe infantile-onset neurodegenerative condition. We identified two unique ATP7A missense mutations (p.P1386S and p.T994I) in males with distal motor neuropathy in two families. These molecular alterations impact highly conserved amino acids in the carboxyl half of ATP7A and do not directly involve the copper transporter's known critical functional domains. Studies of p.P1386S revealed normal ATP7A mRNA and protein levels, a defect in ATP7A trafficking, and partial rescue of a S. cerevisiae copper transport knockout. Although ATP7A mutations are typically associated with severe Menkes disease or its milder allelic variant, occipital horn syndrome, we demonstrate here that certain missense mutations at this locus can cause a syndrome restricted to progressive distal motor neuropathy without overt signs of systemic copper deficiency. This previously unrecognized genotype-phenotype correlation suggests an important role of the ATP7A copper transporter in motor-neuron maintenance and function. Copyright 2010 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20170900      PMCID: PMC2833394          DOI: 10.1016/j.ajhg.2010.01.027

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  45 in total

Review 1.  Cellular multitasking: the dual role of human Cu-ATPases in cofactor delivery and intracellular copper balance.

Authors:  Svetlana Lutsenko; Arnab Gupta; Jason L Burkhead; Vesna Zuzel
Journal:  Arch Biochem Biophys       Date:  2008-05-21       Impact factor: 4.013

Review 2.  The multi-layered regulation of copper translocating P-type ATPases.

Authors:  Nicholas A Veldhuis; Ann P Gaeth; Richard B Pearson; Kipros Gabriel; James Camakaris
Journal:  Biometals       Date:  2009-01-07       Impact factor: 2.949

3.  Clinical and electrodiagnostic findings in copper deficiency myeloneuropathy.

Authors:  B P Goodman; E P Bosch; M A Ross; C Hoffman-Snyder; D D Dodick; B E Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-05-21       Impact factor: 10.154

Review 4.  Genetics of motor neuron disorders: new insights into pathogenic mechanisms.

Authors:  Patrick A Dion; Hussein Daoud; Guy A Rouleau
Journal:  Nat Rev Genet       Date:  2009-10-13       Impact factor: 53.242

5.  Response to oral supplementation in copper deficiency myeloneuropathy.

Authors:  Praful Kelkar; Shereen Chang; Suraj A Muley
Journal:  J Clin Neuromuscul Dis       Date:  2008-09

6.  X-linked distal hereditary motor neuropathy maps to the DSMAX locus on chromosome Xq13.1-q21.

Authors:  M Kennerson; G Nicholson; B Kowalski; K Krajewski; D El-Khechen; S Feely; S Chu; M Shy; J Garbern
Journal:  Neurology       Date:  2009-01-20       Impact factor: 9.910

7.  Clinical outcomes in Menkes disease patients with a copper-responsive ATP7A mutation, G727R.

Authors:  Jingrong Tang; Anthony Donsante; Vishal Desai; Nicholas Patronas; Stephen G Kaler
Journal:  Mol Genet Metab       Date:  2008-08-26       Impact factor: 4.797

8.  Case of sensory ataxic ganglionopathy-myelopathy in copper deficiency.

Authors:  Gabriella Zara; Francesca Grassivaro; Filippo Brocadello; Renzo Manara; Francesco Francini Pesenti
Journal:  J Neurol Sci       Date:  2008-11-20       Impact factor: 3.181

9.  When metals compete: a case of copper-deficiency myeloneuropathy and anemia.

Authors:  Rebecca I Spain; Thomas P Leist; Eduardo A De Sousa
Journal:  Nat Clin Pract Neurol       Date:  2009-02

10.  Translational read-through of a nonsense mutation in ATP7A impacts treatment outcome in Menkes disease.

Authors:  Stephen G Kaler; Jingrong Tang; Anthony Donsante; Christine R Kaneski
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

View more
  70 in total

1.  Molecular and biochemical characterization of a unique mutation in CCS, the human copper chaperone to superoxide dismutase.

Authors:  Peter Huppke; Cornelia Brendel; Georg Christoph Korenke; Iris Marquardt; Anthony Donsante; Ling Yi; Julia D Hicks; Peter J Steinbach; Callum Wilson; Orly Elpeleg; Lisbeth Birk Møller; John Christodoulou; Stephen G Kaler; Jutta Gärtner
Journal:  Hum Mutat       Date:  2012-05-16       Impact factor: 4.878

Review 2.  Research challenges in central nervous system manifestations of inborn errors of metabolism.

Authors:  P I Dickson; A R Pariser; S C Groft; R W Ishihara; D E McNeil; D Tagle; D J Griebel; S G Kaler; J W Mink; E G Shapiro; K J Bjoraker; L Krivitzky; J M Provenzale; A Gropman; P Orchard; G Raymond; B H Cohen; R D Steiner; S F Goldkind; R M Nelson; E Kakkis; M C Patterson
Journal:  Mol Genet Metab       Date:  2010-12-02       Impact factor: 4.797

3.  Autosomal dominant late-onset spinal motor neuronopathy is linked to a new locus on chromosome 22q11.2-q13.2.

Authors:  Sini Penttilä; Manu Jokela; Peter Hackman; Anna Maija Saukkonen; Jari Toivanen; Bjarne Udd
Journal:  Eur J Hum Genet       Date:  2012-04-25       Impact factor: 4.246

4.  Analysis of dynein intermediate chains, light intermediate chains and light chains in a cohort of hereditary peripheral neuropathies.

Authors:  Shelisa Tey; Azlina Ahmad-Annuar; Alexander P Drew; Nortina Shahrizaila; Garth A Nicholson; Marina L Kennerson
Journal:  Neurogenetics       Date:  2014-07-16       Impact factor: 2.660

5.  Clinical utility gene card for: Menkes disease.

Authors:  Zeynep Tümer; Leo Klomp
Journal:  Eur J Hum Genet       Date:  2011-04-13       Impact factor: 4.246

Review 6.  ATP7A-related copper transport diseases-emerging concepts and future trends.

Authors:  Stephen G Kaler
Journal:  Nat Rev Neurol       Date:  2011-01       Impact factor: 42.937

7.  ATP7A trafficking and mechanisms underlying the distal motor neuropathy induced by mutations in ATP7A.

Authors:  Ling Yi; Stephen Kaler
Journal:  Ann N Y Acad Sci       Date:  2014-04-22       Impact factor: 5.691

8.  The mild form of menkes disease: a 34 year progress report on the original case.

Authors:  M C Tchan; B Wilcken; J Christodoulou
Journal:  JIMD Rep       Date:  2012-10-13

Review 9.  Molecular basis of neurodegeneration and neurodevelopmental defects in Menkes disease.

Authors:  Stephanie Zlatic; Heather Skye Comstra; Avanti Gokhale; Michael J Petris; Victor Faundez
Journal:  Neurobiol Dis       Date:  2015-01-10       Impact factor: 5.996

10.  Maternofetal and neonatal copper requirements revealed by enterocyte-specific deletion of the Menkes disease protein.

Authors:  Yanfang Wang; Sha Zhu; Victoria Hodgkinson; Joseph R Prohaska; Gary A Weisman; Jonathan D Gitlin; Michael J Petris
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-11       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.